In addition, we showed that both reduced TET2 expression and low genomic 5-hmc correlate with poor survival while survival is not affected by level of TET3. These results strongly suggest that the decrease in 5-hmc found in acute ATLL patients is the direct consequence of TET2 downregulation. Here, TET2 is linked to adult T-cell leukemia/lymphoma.